438 related articles for article (PubMed ID: 28954590)
1. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study.
Wang H; Xu J; Zhang X; Ren YL; Cheng M; Guo ZL; Zhang JC; Cheng H; Xing GL; Wang SX; Yu F; Zhao MH
Lupus; 2018 Apr; 27(4):545-555. PubMed ID: 28954590
[TBL] [Abstract][Full Text] [Related]
2. Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis.
Satoskar AA; Brodsky SV; Nadasdy G; Bott C; Rovin B; Hebert L; Nadasdy T
Lupus; 2011 Nov; 20(13):1396-403. PubMed ID: 22095887
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological significance of immune complex (IC) along the tubular basement membrane (TBM) in lupus nephritis].
Shinbo H; Kobayashi K; Boku S; Akagi T; Totsuka D; Saito K; Kitazawa K; Ito S; Sugizaki T
Arerugi; 1993 Aug; 42(8):941-7. PubMed ID: 8250734
[TBL] [Abstract][Full Text] [Related]
4. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.
Ding Y; Yu X; Wu L; Tan Y; Qu Z; Yu F
Front Immunol; 2021; 12():654652. PubMed ID: 34276649
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural changes of tubular basement membranes in immunologic renal tubular lesions in humans.
Orfila C; Vega-Vidallé C; Suc JM
Ultrastruct Pathol; 1990; 14(2):121-8. PubMed ID: 2189251
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
[TBL] [Abstract][Full Text] [Related]
8. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
[TBL] [Abstract][Full Text] [Related]
9. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis.
Nossent H; Berden J; Swaak T
Lupus; 2000; 9(7):504-10. PubMed ID: 11035415
[TBL] [Abstract][Full Text] [Related]
10. Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells.
Omokawa A; Wakui H; Okuyama S; Togashi M; Ohtani H; Komatsuda A; Ichinohasama R; Sawada K
Clin Nephrol; 2008 Jun; 69(6):436-44. PubMed ID: 18538120
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J
J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
[TBL] [Abstract][Full Text] [Related]
12. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
Wener MH; Mannik M; Schwartz MM; Lewis EJ
Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions.
Wu LH; Yu F; Tan Y; Qu Z; Chen MH; Wang SX; Liu G; Zhao MH
Kidney Int; 2013 Apr; 83(4):715-23. PubMed ID: 23302713
[TBL] [Abstract][Full Text] [Related]
14. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
Yang XW; Tan Y; Yu F; Zhao MH
Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
[TBL] [Abstract][Full Text] [Related]
15. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center.
Li Q; Song D; Wang F; Tan Y; Yu F; Zhao M
ScientificWorldJournal; 2014; 2014():212597. PubMed ID: 24672300
[TBL] [Abstract][Full Text] [Related]
17. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
18. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
19. Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China.
Tan Y; Luan ZQ; Hao JB; Song D; Yu F; Zhao MH
Lupus; 2018 Mar; 27(3):389-398. PubMed ID: 28786769
[TBL] [Abstract][Full Text] [Related]
20. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis.
Mori Y; Kishimoto N; Yamahara H; Kijima Y; Nose A; Uchiyama-Tanaka Y; Fukui M; Kitamura T; Tokoro T; Masaki H; Nagata T; Umeda Y; Nishikawa M; Iwasaka T
Clin Exp Nephrol; 2005 Mar; 9(1):79-84. PubMed ID: 15830279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
